INDEPENDENT ANTI-DOPING REFERENCE2026 · CHECKED 08 NOV 2027 PUBLISHED ↗
WADAFUK!?
Source-checked regulatory summary

Methylephedrine.

S6
Regulatory coverage only

Checked 2026-11-10. Independent clinical review has not been completed. WADAFUK is independent of WADA and does not provide medical advice or an individual anti-doping determination.

Regulatory summary with limited context. A compound-specific science and safety review is still missing.

REGULATORY SUMMARY2026 LIST

Conditional restriction

WADA 2026: S6.B, specified, prohibited in competition above a urine concentration of 10 micrograms/mL. The future 2027 List retains this rule. See the separate S5 combination condition. [1] [2]

2026 and 2027 List, S6.B, printed pp.15–16; introductory definitions p.3 · 2026 rules apply from 1 January 2026. Any 2027 material below concerns future rules from 1 January 2027; it is not current clearance.

EVIDENCE / 01

Threshold and combination conditions

When a prohibited diuretic or masking agent is detected with formoterol, salbutamol, cathine, ephedrine, methylephedrine or pseudoephedrine, S5 has an additional TUE requirement even below the usual threshold. The note expressly excludes qualifying carbonic-anhydrase-inhibitor eye administration and local dental felypressin. It is not a dosing or test-clearance rule. [1] [2]

Limits of this evidence
  • A urine threshold cannot be converted into a safe dose or a guaranteed test result.
EVIDENCE / 02

Research coverage

Rule-only entry: the WADA classification has been checked. No molecule-specific clinical, health-risk or current-product claim is published from the shared cluster notes. [1] [2]

Limits of this evidence
  • Sparse coverage. A dedicated primary-source clinical and exposure review remains incomplete.

What remains uncertain

  • Substantive molecule-specific review remains incomplete; shared evidence for related compounds was not generalized to this record.
  • Educational synthesis only; not individualized medical advice, a TUE decision or a sanction prediction.
TRACEABILITY

Check the sources.

These are concise editorial paraphrases of selected sources, not a systematic review or a reproduction of source tables. Access depth is shown for each reference; an abstract-only check cannot resolve details found only in a full paper.

  1. WADA 2026 Prohibited List ↗Accessed 2026-11-10 · relevant full-text sections independently opened and inspected

    Introduction p.3 · S6 pp.15–16 · S5 p.12

  2. WADA 2027 Prohibited List, 4 November revision ↗Accessed 2026-11-10 · relevant full-text sections independently opened and inspected · FUTURE 2027 SOURCE

    Introduction p.3 · S6 pp.15–16 · S5 p.12

Before acting on this information

Check the current official WADA List and the relevant anti-doping authority for your sport, product, route and circumstances. Do not stop or change necessary treatment based on this page. Ask a qualified clinician about health decisions. Missing evidence does not establish safety.

Something wrong? Prepare a correction draft ↗